Abstract: A catalyst for methane synthesis is made up from layered double hydroxides represented by the following general formula (1). [M2+1-xM3+x(OH)2]x+[An?x/n·yH2O]??(1) In formula (1), M2+ is Ni2+ and M3+ is Al3+ or Cr3+. Further, An? is CO32?. Furthermore, the term x lies within a range of 0.19 to 0.34 (0.19?x?0.34), and y is 0 or a positive integer.

Abstract: An electrosynthesis system is equipped with an electrolysis device that carries out electrolysis on carbon dioxide gas and water vapor, a synthesizing device that synthesizes a hydrocarbon gas from hydrogen gas and carbon monoxide gas that are generated by the electrolysis, and a control device. The control device adjusts a flow rate of the water vapor supplied to the electrolysis device, in a manner so that a first concentration ratio, which is a concentration ratio between the hydrogen gas and the carbon monoxide gas in a mixed gas discharged from the electrolysis device and containing the hydrogen gas and the carbon monoxide gas, becomes a predetermined target concentration ratio.

Abstract: According to one embodiment, a semiconductor structure includes a substrate including silicon crystal, a first layer including AlN crystal, and an intermediate region provided between the silicon crystal and the AlN crystal. The intermediate region includes Al and nitrogen. A direction from the silicon crystal to the AlN crystal is along a first direction. A third lattice plane spacing in the first direction of a lattice of Al atoms in the intermediate region is longer than a first lattice plane spacing in the first direction of the silicon crystal and longer than a second lattice plane spacing in the first direction of the AlN crystal.

Abstract: Provided is an oral composition comprising (a) a high-intensity sweetener in an amount corresponding to a sweetness intensity X1, (b) an intrinsic phospholipid, (c) 60 mg/100 mL or less of sodium, and (d) a foreign phospholipid in an amount less than a taste recognition threshold, wherein the oral composition has a sweetness of a sweetness intensity X2 exhibited by the components (a) and (b), and a sweetness of a sweetness intensity X3 exhibited by the components (a) to (d), respectively, and 0.1<X2<X3 is satisfied.

Abstract: A medical image processing apparatus according to an embodiment includes processing circuitry. The processing circuitry acquires a plurality of projection data based on an output signal from an X-ray detector that rotates around a subject, performs reconstruction filter processing on the plurality of acquired projection data, the reconstruction filter processing being included in reconstruction regarding the plurality of projection data, generates correction information on a sensitivity difference area formed in the plurality of projection data due to differences in sensitivity of the X-ray detector, on the basis of a processing result of the reconstruction filter processing, performs correction processing on the plurality of projection data on the basis of the correction information, and performs reconstruction processing including the reconstruction filter processing on the plurality of projection data subjected to the correction processing.

Abstract: Provided is an oral composition comprising (a) a high-intensity sweetener in an amount corresponding to a sweetness intensity X1, (b) 60 mg/100 mL or less of sodium, and (c) a phospholipid in an amount less than a taste recognition threshold, wherein the oral composition has a sweetness of a sweetness intensity X2 exhibited by the components (a) to (c), respectively, and 0.1<X1<X2 is satisfied.

Abstract: A fluid supply apparatus that can eliminate the need for a power supply source, and store fluid efficiently. The apparatus may comprise a first balloon that is formed of an elastic body to be capable of storing the fluid, a second balloon that is formed of an elastic body to be capable of storing the fluid, and has a larger contraction force than a contraction force of the first balloon, a support member that supports both of the first balloon and the second balloon, and a casing that houses the first balloon and the second balloon, and defines inflation ranges of the first balloon and the second balloon, in which the support member has a flow path formed to permit fluid communication between an interior of the first balloon and an interior of the second balloon.

Abstract: An electrolytic cell includes a membrane electrode assembly, a pair of separators, a gas supply flow path, and a gas discharge flow path. A fuel electrode of the membrane electrode assembly contains a catalytic material that activates the electrolytic reactions of the raw material gas, and the amount of the catalytic material contained in the fuel electrode increases from the upstream side to the downstream side of the gas supply flow path.

Abstract: An electrosynthesis system is equipped with an adjustment device that adjusts a flow rate of a hydrogen gas supplied from a hydrogen gas storage device to a generated gas flow path, and a flow rate of a carbon monoxide gas supplied from the carbon monoxide gas storage device to the generated gas flow path, based on a detection result of a first concentration sensor, in a manner so that the hydrogen gas and the carbon monoxide gas are supplied to a hydrocarbon synthesizing device at a predetermined concentration ratio.

Abstract: An electrolysis system includes: an oxygen consumption device that consumes, using hydrogen, oxygen gas in exhaust gas; a valve device that is configured to switch a supply destination of the hydrogen-containing gas output from a solid oxide electrolysis stack to either one of the oxygen consumption device or a generating device; and a control device that controls the valve device according to the oxygen concentration in the exhaust gas output from the oxygen consumption device to switch the supply destination of the hydrogen-containing gas.

Abstract: Provided is an immunostimulator containing glucan and having an immunostimulatory effect. This immunostimulator contains glucan and lipid derived from yeast cell wall and is water-insoluble. A total content percentage of glucan and lipid is 80 mass % or more, and a content ratio of lipid to glucan is 0.1 or more and 0.4 or less.